VRCAVerrica Pharmaceuticals Inc.

$57M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M

Gross Profit

$12M100.0% margin

Operating Income

$60,0000.5% margin

Net Income

-$936,000-7.8% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$108M

Total Liabilities

$46M

Stockholders' Equity

$62M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$0	—
Gross Profit	$12M	$0	—
Operating Income	$60,000	-$10M	+100.6%
Net Income	-$936,000	-$10M	+90.5%

VRCA Q1 2021 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena